Table 3.
Primary Outcomes (SPEM, PPI, Auditory ERP) in the Schizophrenia and Psychotic Bipolar I Disorder Probands, and Healthy Controls
| SZP vs BDP | SZP vs HC | BDP vs HC | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Measure | χ 2 | P-Value | λ | D | χ2 | P-Value | λ | d | χ 2 | P-Value | λ | d |
| SPEM (gain) | ||||||||||||
| MPG_9.9 | 0.00 | .98 | 0.05 | 0.09 | 5.91 | .02 | −6.93 | −0.56 | 5.49 | .02 | −6.00 | −0.57 |
| MPG_18.7 | 0.61 | .43 | 1.24 | 0.22 | 3.83 | .05 | −3.95 | −0.33 | 6.09 | .01 | −4.70 | −0.52 |
| MPG_25.0 | 0.04 | .84 | 0.28 | 0.13 | 6.49 | .01 | −4.22 | −0.53 | 7.25 | .01 | −4.59 | −0.67 |
| PPG_9.9 | 0.04 | .84 | 0.40 | 0.09 | 9.41 | .00 | −7.34 | −0.70 | 9.02 | .00 | −7.08 | −0.73 |
| PPG_18.7 | 0.00 | .99 | 0.02 | 0.00 | 12.44 | .00 | −7.27 | −0.83 | 12.83 | .00 | −9.49 | −0.91 |
| PPG_25.0 | 0.07 | .79 | 0.44 | 0.14 | 9.61 | .00 | −6.36 | −0.69 | 9.12 | .00 | −5.47 | −0.73 |
| PPI and PPF (Δ%)a | ||||||||||||
| PPI | 0.00 | .97 | 0.00 | −0.10 | 0.43 | .51 | −0.01 | −0.22 | 0.21 | .65 | −0.01 | −0.12 |
| PPF | 1.30 | .25 | −0.01 | −0.13 | 0.00 | .98 | 0.00 | −0.03 | 0.06 | .80 | 0.00 | 0.08 |
| Auditory ERP (dB) | ||||||||||||
| Beta | 0.00 | .96 | 0.00 | 0.07 | 5.81 | .02 | −0.17 | −0.90 | 5.37 | .02 | −0.19 | −0.90 |
| Theta/alpha | 0.19 | .66 | −0.02 | −0.10 | 7.21 | .01 | −0.17 | −0.93 | 5.24 | .02 | −0.15 | −0.84 |
aGender comparisons (ordinary regression): (1) SZP: PPI, t = 0.37, P = .71, λ = 4.85; PPF, t = 1.19, P = .24, λ = 14.80; (2) BDP: PPI, t = −0.89, P = .38, λ = −11.16; PPF, t = 0.62, P = .54, λ = 9.46; (3) HC: PPI, t = −0.05, P = .96, λ = −0.44; PPF, t = −2.51, P = .02, λ =−48.75.